Detalles de la búsqueda
1.
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 24(7): 798-810, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37290468
2.
Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma.
BMC Cancer
; 23(1): 7, 2023 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36597072
3.
Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.
Eur Radiol
; 33(5): 3682-3692, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36735041
4.
Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissection.
BMC Cancer
; 22(1): 1129, 2022 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36329397
5.
First-Line Immunochemotherapy Versus Palliative Chemotherapy Plus Definitive Radiation Therapy for de novo Metastatic Nasopharyngeal Carcinoma: A Matched Cohort Study.
Cancer Control
; 29: 10732748221124868, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36047451
6.
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.
Eur J Nucl Med Mol Imaging
; 48(8): 2586-2598, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33420610
7.
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Eur Radiol
; 31(7): 5222-5233, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33416977
8.
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.
BMC Cancer
; 20(1): 89, 2020 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32013967
9.
Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
J Transl Med
; 17(1): 186, 2019 06 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31159814
10.
Maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients.
BMC Cancer
; 19(1): 908, 2019 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31511059
11.
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.
BMC Cancer
; 19(1): 92, 2019 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30665378
12.
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.
Lancet Oncol
; 19(4): 461-473, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29501366
13.
Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysis.
BMC Cancer
; 18(1): 1297, 2018 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30594171
14.
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma.
BMC Cancer
; 18(1): 1279, 2018 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30572856
15.
Overexpression of acylglycerol kinase is associated with poorer prognosis and lymph node metastasis in nasopharyngeal carcinoma.
Tumour Biol
; 37(3): 3349-57, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26443540
16.
Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.
Radiother Oncol
; 191: 110051, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38135184
17.
Identifying the prognostic value of MRI-based tumor response and predicting the risk of radio-resistance in re-radiotherapy for locally recurrent nasopharyngeal carcinoma.
Radiother Oncol
; 183: 109635, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36963444
18.
Can the prognosis of individual patients with nasopharyngeal carcinoma be predicted using a routine blood test at admission?
Radiother Oncol
; 179: 109445, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36566987
19.
A new prognostic model for predicting outcomes of patients with recurrent or metastatic nasopharyngeal carcinoma receiving subsequent line (≥2 lines) anti-programmed death-1 monotherapy.
Oral Oncol
; 139: 106336, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36827901
20.
Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial.
Lancet Reg Health West Pac
; 40: 100895, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37691885